Reliance submitted a proposal for the use of Niclosamide in COVID-19 treatment, and is developing detection kits, low-cost sanitisers, and oxygen generators
Reliance submits proposal for using Niclosamide as COVID drug
Niclosamide, a drug on the World Health Organisation s list of essential medicines, has been used to treat tapeworm infestation for more than 50 years.
Share Via Email
| A+A A- By PTI
NEW DELHI: Reliance Industries Ltd s R&D arm has proposed the use of Niclosamide - the drug used to treat tapeworm infestation - for treating COVID-19 patients.
Niclosamide, a drug on the World Health Organisation s list of essential medicines, has been used to treat tapeworm infestation for more than 50 years.
The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.
Read more about Reliance submits proposal for potential coronavirus drug Niclosamide on Business Standard. Reliance Industries Ltd s R&D arm has proposed the use of Niclosamide - the drug used to treat tapeworm infestation - for treating COVID-19 patients.Niclosamide, a drug on the World Health Organisation s list of essential medicines, has been used
URL copied
A health worker administers a dose of the Covid-19 vaccine to a benificiary, in Bengaluru.
Reliance Industries Ltd s R&D arm has proposed the use of Niclosamide - the drug used to treat tapeworm infestation - for treating COVID-19 patients.
Niclosamide, a drug on the World Health Organisation s list of essential medicines, has been used to treat tapeworm infestation for more than 50 years.
The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04. The company submitted a proposal for the application of Niclosamide as a potential drug against COVID-19, the firm s latest annual report said. The drug regulator will now evaluate the proposal for public use.